Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Alan D'Andrea

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Cell Line

Living Beings

Mice

Physiology

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
16
Grompe, Markus
15
Taniguchi, Toshiyasu
12
Garcia-Higuera, Irene
10
Kupfer, Gary
10
Barber, Dwayne
9
Joenje, Hans
8
Lodish, Harvey
7
Mathew, Christopher
7
Mathey-Prevot, Bernard
7
Yamashita, Takayuki
6
Kuang, Yanan
6
Andreassen, Paul
5
Moreau, Lisa
5
Suliman, A
5
Zon, Leonard

Sign-in to see all Coauthors

Publications

TOP 3
Johnson Neil; Cai Dongpo; Kennedy Richard D; Pathania Shailja; Arora Mansi; Li Yu-Chen; D'Andrea Alan D; Parvin Jeffrey D; Shapiro Geoffrey I
Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage.
Kee Younghoon; Kim Jung Min; D'Andrea Alan D;
Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis.
Kim Jung Min; Parmar Kalindi; Huang Min; Weinstock David M; Ruit Carrie Ann; Kutok Jeffrey L; D'Andrea Alan D
Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Alan D'Andrea (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Johnson Neil; Cai Dongpo; Kennedy Richard D; Pathania Shailja; Arora Mansi; Li Yu-Chen; D'Andrea Alan D; Parvin Jeffrey D; Shapiro Geoffrey I
Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage.
Molecular cell 2009;35(3):327-39.
2009: Kee Younghoon; Kim Jung Min; D'Andrea Alan D;
Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis.
Genes & development 2009;23(5):555-60.
2009: Kim Jung Min; Parmar Kalindi; Huang Min; Weinstock David M; Ruit Carrie Ann; Kutok Jeffrey L; D'Andrea Alan D
Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.
Developmental cell 2009;16(2):314-20.
2009: Cohn Martin A; Kee Younghoon; Haas Wilhelm; Gygi Steven P; D'Andrea Alan D
UAF1 is a subunit of multiple deubiquitinating enzyme complexes.
The Journal of biological chemistry 2009;284(8):5343-51.
2008: Mirchandani Kanchan D; McCaffrey Ryan M; D'Andrea Alan D
The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly.
DNA repair 2008;7(6):902-11.
2008: Sidi Samuel; Sanda Takaomi; Kennedy Richard D; Hagen Andreas T; Jette Cicely A; Hoffmans Raymond; Pascual Jennifer; Imamura Shintaro; Kishi Shuji; Amatruda James F; Kanki John P; Green Douglas R; D'Andrea Alan A; Look A Thomas
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3.
Cell 2008;133(5):864-77.
2008: Kim Jung Min; Kee Younghoon; Gurtan Allan; D'Andrea Alan D
Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24.
Blood 2008;111(10):5215-22.
2007: Cohn Martin A; Kowal Przemyslaw; Yang Kailin; Haas Wilhelm; Huang Tony T; Gygi Steven P; D'Andrea Alan D
A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway.
Molecular cell 2007;28(5):786-97.
2007: Kennedy Richard D; Chen Clark C; Stuckert Patricia; Archila Elyse M; De la Vega Michelle A; Moreau Lisa A; Shimamura Akiko; D'Andrea Alan D
Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
The Journal of clinical investigation 2007;117(5):1440-9.
2007: Chen Clark C; Taniguchi Toshiyasu; D'Andrea Alan
The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents.
Journal of molecular medicine (Berlin, Germany) 2007;85(5):497-509.
2007: Smogorzewska Agata; Matsuoka Shuhei; Vinciguerra Patrizia; McDonald E Robert; Hurov Kristen E; Luo Ji; Ballif Bryan A; Gygi Steven P; Hofmann Kay; D'Andrea Alan D; Elledge Stephen J
Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.
Cell 2007;129(2):289-301.
2007: Wang Xiaozhe; Kennedy Richard D; Ray Kallol; Stuckert Patricia; Ellenberger Tom; D'Andrea Alan D
Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.
Molecular and cellular biology 2007;27(8):3098-108.
2007: Kowal Przemyslaw; Gurtan Allan M; Stuckert Patricia; D'Andrea Alan D; Ellenberger Tom
Structural determinants of human FANCF protein that function in the assembly of a DNA damage signaling complex.
The Journal of biological chemistry 2007;282(3):2047-55.
2006: Chen Clark C; Motegi Akira; Hasegawa Yuko; Myung Kyungjae; Kolodner Richard; D'Andrea Alan
Genetic analysis of ionizing radiation-induced mutagenesis in Saccharomyces cerevisiae reveals TransLesion Synthesis (TLS) independent of PCNA K164 SUMOylation and ubiquitination.
DNA repair 2006;5(12):1475-88.
2006: Huang Tony T; D'Andrea Alan D
HAUSP hunting the FOX(O).
Nature cell biology 2006;8(10):1043-5.
2006: Ho Gary P H; Margossian Steven; Taniguchi Toshiyasu; D'Andrea Alan D
Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.
Molecular and cellular biology 2006;26(18):7005-15.
2006: Gurtan Allan M; D'Andrea Alan D
Dedicated to the core: understanding the Fanconi anemia complex.
DNA repair 2006;5(9-10):1119-25.
2006: Machida Yuichi J; Machida Yuka; Chen Yuefeng; Gurtan Allan M; Kupfer Gary M; D'Andrea Alan D; Dutta Anindya
UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation.
Molecular cell 2006;23(4):589-96.
2006: Kennedy Richard D; D'Andrea Alan D
DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3799-808.
2006: Mirchandani Kanchan D; D'Andrea Alan D
The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair.
Experimental cell research 2006;312(14):2647-53.
2006: Taniguchi Toshiyasu; D'Andrea Alan D
Molecular pathogenesis of Fanconi anemia: recent progress.
Blood 2006;107(11):4223-33.
2006: Huang Tony T; D'Andrea Alan D
Regulation of DNA repair by ubiquitylation.
Nature reviews. Molecular cell biology 2006;7(5):323-34.
2006: Andreassen Paul R; Ho Gary P H; D'Andrea Alan D
DNA damage responses and their many interactions with the replication fork.
Carcinogenesis 2006;27(5):883-92.
2006: Chirnomas Deborah; Taniguchi Toshiyasu; de la Vega Michelle; Vaidya Ami P; Vasserman Maria; Hartman Anne-Renee; Kennedy Richard; Foster Rosemary; Mahoney Jennifer; Seiden Michael V; D'Andrea Alan D
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway.
Molecular cancer therapeutics 2006;5(4):952-61.
2006: Zhu Andrew X; D'Andrea Alan D; Sahani Dushyant V; Hasserjian Robert P
Case records of the Massachusetts General Hospital. Case 13-2006. A 50-year-old man with a painful bone mass and lesions in the liver.
The New England journal of medicine 2006;354(17):1828-37.
2006: Huang Tony T; Nijman Sebastian M B; Mirchandani Kanchan D; Galardy Paul J; Cohn Martin A; Haas Wilhelm; Gygi Steven P; Ploegh Hidde L; Bernards René; D'Andrea Alan D
Regulation of monoubiquitinated PCNA by DUB autocleavage.
Nature cell biology 2006;8(4):339-47.
2006: Gurtan Allan M; Stuckert Patricia; D'Andrea Alan D
The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly.
The Journal of biological chemistry 2006;281(16):10896-905.
2006: Mankad Anuj; Taniguchi Toshiyasu; Cox Barbara; Akkari Yassmine; Rathbun R Keaney; Lucas Lora; Bagby Grover; Olson Susan; D'Andrea Alan; Grompe Markus
Natural gene therapy in monozygotic twins with Fanconi anemia.
Blood 2006;107(8):3084-90.
2006: Howlett Niall G; Scuric Zorica; D'Andrea Alan D; Schiestl Robert H
Impaired DNA double strand break repair in cells from Nijmegen breakage syndrome patients.
DNA repair 2006;5(2):251-7.
2005: Kennedy Richard D; D'Andrea Alan D
The Fanconi Anemia/BRCA pathway: new faces in the crowd.
Genes & development 2005;19(24):2925-40.
2005: Park Woo-Hyun; Margossian Steven; Horwitz Andrew A; Simons Amanda M; D'Andrea Alan D; Parvin Jeffrey D
Direct DNA binding activity of the Fanconi anemia D2 protein.
The Journal of biological chemistry 2005;280(25):23593-8.
2005: New Helen V; Cale C M; Tischkowitz M; Jones A; Telfer P; Veys P; D'Andrea A; Mathew C G; Hann I
Nijmegen breakage syndrome diagnosed as Fanconi anaemia.
Pediatric blood & cancer 2005;44(5):494-9.
2005: Levine Ross L; Wadleigh Martha; Cools Jan; Ebert Benjamin L; Wernig Gerlinde; Huntly Brian J P; Boggon Titus J; Wlodarska Iwona; Clark Jennifer J; Moore Sandra; Adelsperger Jennifer; Koo Sumin; Lee Jeffrey C; Gabriel Stacey; Mercher Thomas; D'Andrea Alan; Fröhling Stefan; Döhner Konstanze; Marynen Peter; Vandenberghe Peter; Mesa Ruben A; Tefferi Ayalew; Griffin James D; Eck Michael J; Sellers William R; Meyerson Matthew; Golub Todd R; Lee Stephanie J; Gilliland D Gary
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Cancer cell 2005;7(4):387-97.
2005: Howlett Niall G; Taniguchi Toshiyasu; Durkin Sandra G; D'Andrea Alan D; Glover Thomas W
The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability.
Human molecular genetics 2005;14(5):693-701.
2005: Nijman Sebastian M B; Huang Tony T; Dirac Annette M G; Brummelkamp Thijn R; Kerkhoven Ron M; D'Andrea Alan D; Bernards René
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.
Molecular cell 2005;17(3):331-9.
2005: Montes de Oca Rocio; Andreassen Paul R; Margossian Steven P; Gregory Richard C; Taniguchi Toshiyasu; Wang Xiaozhe; Houghtaling Scott; Grompe Markus; D'Andrea Alan D
Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.
Blood 2005;105(3):1003-9.
2005: Soulier Jean; Leblanc Thierry; Larghero Jérôme; Dastot Hélène; Shimamura Akiko; Guardiola Philippe; Esperou Hélène; Ferry Christèle; Jubert Charlotte; Feugeas Jean-Paul; Henri Annie; Toubert Antoine; Socié Gérard; Baruchel André; Sigaux François; D'Andrea Alan D; Gluckman Eliane
Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.
Blood 2005;105(3):1329-36.
2005: Nakanishi Koji; Yang Yun-Gui; Pierce Andrew J; Taniguchi Toshiyasu; Digweed Martin; D'Andrea Alan D; Wang Zhao-Qi; Jasin Maria
Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(4):1110-5.
2004: Andreassen Paul R; D'Andrea Alan D; Taniguchi Toshiyasu
ATR couples FANCD2 monoubiquitination to the DNA-damage response.
Genes & development 2004;18(16):1958-63.
2004: Wang XiaoZhe; D'Andrea Alan D
The interplay of Fanconi anemia proteins in the DNA damage response.
DNA repair 2004;3(8-9):1063-9.
2004: Wang XiaoZhe; Andreassen Paul R; D'Andrea Alan D
Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.
Molecular and cellular biology 2004;24(13):5850-62.
2004: Hirsch Betsy; Shimamura Akiko; Moreau Lisa; Baldinger Shari; Hag-alshiekh Maha; Bostrom Bruce; Sencer Susan; D'Andrea Alan D
Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.
Blood 2004;103(7):2554-9.
2003: Liu Ting Xi; Howlett Niall G; Deng Min; Langenau David M; Hsu Karl; Rhodes Jennifer; Kanki John P; D'Andrea Alan D; Look A Thomas
Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis.
Developmental cell 2003;5(6):903-14.
2003: Tischkowitz Marc; Ameziane Najim; Waisfisz Quinten; De Winter Johan P; Harris Richard; Taniguchi Toshiyasu; D'Andrea Alan; Hodgson Shirley V; Mathew Christopher G; Joenje Hans
Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia.
British journal of haematology 2003;123(3):469-71.
2003: Shimamura Akiko; D'Andrea Alan D
Subtyping of Fanconi anemia patients: implications for clinical management.
Blood 2003;102(9):3459.
2003: D'Andrea Alan D
The Fanconi road to cancer.
Genes & development 2003;17(16):1933-6.
2003: Jin Shenghao; Mao Hua; Schnepp Robert W; Sykes Stephen M; Silva Albert C; D'Andrea Alan D; Hua Xianxin
Menin associates with FANCD2, a protein involved in repair of DNA damage.
Cancer research 2003;63(14):4204-10.
2003: D'Andrea Alan
Fanconi anemia.
Current biology : CB 2003;13(14):R546.
2003: D'Andrea Alan D
The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.
Cell cycle (Georgetown, Tex.) 2003;2(4):290-2.
2003: Ikeda Hideyuki; Matsushita Maiko; Waisfisz Quinten; Kinoshita Akitoshi; Oostra Anneke B; Nieuwint Aggie W M; De Winter Johan P; Hoatlin Maureen E; Kawai Yohko; Sasaki Masao S; D'Andrea Alan D; Kawakami Yutaka; Joenje Hans
Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
Cancer research 2003;63(10):2688-94.
2003: Taniguchi Toshiyasu; Tischkowitz Marc; Ameziane Najim; Hodgson Shirley V; Mathew Christopher G; Joenje Hans; Mok Samuel C; D'Andrea Alan D
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
Nature medicine 2003;9(5):568-74.
2003: Gregory Richard C; Taniguchi Toshiyasu; D'Andrea Alan D
Regulation of the Fanconi anemia pathway by monoubiquitination.
Seminars in cancer biology 2003;13(1):77-82.
2003: D'Andrea Alan D; Grompe Markus
The Fanconi anaemia/BRCA pathway.
Nature reviews. Cancer 2003;3(1):23-34.
2002: Nakanishi Koji; Taniguchi Toshiyasu; Ranganathan Velvizhi; New Helen V; Moreau Lisa A; Stotsky Maria; Mathew Christopher G; Kastan Michael B; Weaver David T; D'Andrea Alan D
Interaction of FANCD2 and NBS1 in the DNA damage response.
Nature cell biology 2002;4(12):913-20.
2002: Adachi Daiki; Oda Tsukasa; Yagasaki Hiroshi; Nakasato Keiko; Taniguchi Toshiyasu; D'Andrea Alan D; Asano Shigetaka; Yamashita Takayuki
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Human molecular genetics 2002;11(25):3125-34.
2002: Shimamura Akiko; Montes de Oca Rocio; Svenson John L; Haining Nicholas; Moreau Lisa A; Nathan David G; D'Andrea Alan D
A novel diagnostic screen for defects in the Fanconi anemia pathway.
Blood 2002;100(13):4649-54.
2002: Folias Alexandra; Matkovic Mara; Bruun Donald; Reid Sonja; Hejna James; Grompe Markus; D'Andrea Alan; Moses Robb
BRCA1 interacts directly with the Fanconi anemia protein FANCA.
Human molecular genetics 2002;11(21):2591-7.
2002: Taniguchi Toshiyasu; D'Andrea Alan D
The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
Blood 2002;100(7):2457-62.
2002: Taniguchi Toshiyasu; Garcia-Higuera Irene; Andreassen Paul R; Gregory Richard C; Grompe Markus; D'Andrea Alan D
S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.
Blood 2002;100(7):2414-20.
2002: Howlett Niall G; Taniguchi Toshiyasu; Olson Susan; Cox Barbara; Waisfisz Quinten; De Die-Smulders Christine; Persky Nicole; Grompe Markus; Joenje Hans; Pals Gerard; Ikeda Hideyuki; Fox Edward A; D'Andrea Alan D
Biallelic inactivation of BRCA2 in Fanconi anemia.
Science (New York, N.Y.) 2002;297(5581):606-9.
2002: Taniguchi Toshiyasu; Garcia-Higuera Irene; Xu Bo; Andreassen Paul R; Gregory Richard C; Kim Seong-Tae; Lane William S; Kastan Michael B; D'Andrea Alan D
Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
Cell 2002;109(4):459-72.
2002: D'Andrea Alan D; Dahl Niklas; Guinan Eva C; Shimamura Akiko
Marrow failure.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():58-72.
2001: Wilson J B; Johnson M A; Stuckert A P; Trueman K L; May S; Bryant P E; Meyn R E; D'Andrea A D; Jones N J
The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
Carcinogenesis 2001;22(12):1939-46.
2001: Siddique M A; Nakanishi K; Taniguchi T; Grompe M; D'Andrea A D
Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Experimental hematology 2001;29(12):1448-55.
2001: Akkari Y M; Bateman R L; Reifsteck C A; D'Andrea A D; Olson S B; Grompe M
The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase.
Molecular genetics and metabolism 2001;74(4):403-12.
2001: Yagasaki H; Adachi D; Oda T; Garcia-Higuera I; Tetteh N; D'Andrea A D; Futaki M; Asano S; Yamashita T
A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA.
Blood 2001;98(13):3650-7.
2001: D'Andrea A D
Cellular function of the Fanconi anemia pathway.
Nature medicine 2001;7(12):1259-60.
2001: Yang Y; Kuang Y; Montes De Oca R; Hays T; Moreau L; Lu N; Seed B; D'Andrea A D
Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9.
Blood 2001;98(12):3435-40.
2001: Grompe M; D'Andrea A
Fanconi anemia and DNA repair.
Human molecular genetics 2001;10(20):2253-9.
2001: Brooks S E; Ahn J; Mullins C D; Baquet C R; D'Andrea A
Health care cost and utilization project analysis of comorbid illness and complications for patients undergoing hysterectomy for endometrial carcinoma.
Cancer 2001;92(4):950-8.
2001: Baek K H; Mondoux M A; Jaster R; Fire-Levin E; D'Andrea A D
DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.
Blood 2001;98(3):636-42.
2001: Nakanishi K; Moran A; Hays T; Kuang Y; Fox E; Garneau D; Montes de Oca R; Grompe M; D'Andrea A D
Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9.
Experimental hematology 2001;29(7):842-9.
2001: Marcou Y; D'Andrea A; Jeggo P A; Plowman P N
Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;60(1):75-9.
2001: Barber D L; Beattie B K; Mason J M; Nguyen M H; Yoakim M; Neel B G; D'Andrea A D; Frank D A
A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation.
Blood 2001;97(8):2230-7.
2001: Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn M S; Timmers C; Hejna J; Grompe M; D'Andrea A D
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
Molecular cell 2001;7(2):249-62.
2001: Timmers C; Taniguchi T; Hejna J; Reifsteck C; Lucas L; Bruun D; Thayer M; Cox B; Olson S; D'Andrea A D; Moses R; Grompe M
Positional cloning of a novel Fanconi anemia gene, FANCD2.
Molecular cell 2001;7(2):241-8.
2001: Noll M; Bateman R L; D'Andrea A D; Grompe M
Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(1):14-23.
2000: Ney P A; D'Andrea A D
Friend erythroleukemia revisited.
Blood 2000;96(12):3675-80.
2000: Demuth I; Wlodarski M; Tipping A J; Morgan N V; de Winter J P; Thiel M; Gräsl S; Schindler D; D'Andrea A D; Altay C; Kayserili H; Zatterale A; Kunze J; Ebell W; Mathew C G; Joenje H; Sperling K; Digweed M
Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9.
European journal of human genetics : EJHG 2000;8(11):861-8.
2000: Garcia-Higuera I; Kuang Y; Denham J; D'Andrea A D
The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.
Blood 2000;96(9):3224-30.
2000: Kuang Y; Garcia-Higuera I; Moran A; Mondoux M; Digweed M; D'Andrea A D
Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.
Blood 2000;96(5):1625-32.
2000: Joenje H; Levitus M; Waisfisz Q; D'Andrea A; Garcia-Higuera I; Pearson T; van Berkel C G; Rooimans M A; Morgan N; Mathew C G; Arwert F
Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.
American journal of human genetics 2000;67(3):759-62.
1999: Jaster R; Baek K H; D'Andrea A D
Analysis of cis-acting sequences and trans-acting factors regulating the interleukin-3 response element of the DUB-1 gene.
Biochimica et biophysica acta 1999;1446(3):308-16.
1999: Garcia-Higuera I; Kuang Y; Näf D; Wasik J; D'Andrea A D
Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.
Molecular and cellular biology 1999;19(7):4866-73.
1999: Savoia A; Garcia-Higuera I; D'Andrea A D
Nuclear localization of the Fanconi anemia protein FANCC is required for functional activity.
Blood 1999;93(11):4025-6.
1999: Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew C G; D'Andrea A D
A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Experimental hematology 1999;27(4):587-93.
1999: Garcia-Higuera I; Kuang Y; D'Andrea A D
The molecular and cellular biology of Fanconi anemia.
Current opinion in hematology 1999;6(2):83-8.
1999: Garcia-Higuera I; D'Andrea A D
Regulated binding of the Fanconi anemia proteins, FANCA and FANCC.
Blood 1999;93(4):1430-2.
1998: Yamashita T; Kupfer G M; Naf D; Suliman A; Joenje H; Asano S; D'Andrea A D
The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(22):13085-90.
1998: Näf D; Kupfer G M; Suliman A; Lambert K; D'Andrea A D
Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization.
Molecular and cellular biology 1998;18(10):5952-60.
1998: Pulsipher M; Kupfer G M; Naf D; Suliman A; Lee J S; Jakobs P; Grompe M; Joenje H; Sieff C; Guinan E; Mulligan R; D'Andrea A D
Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.
Molecular medicine (Cambridge, Mass.) 1998;4(7):468-79.
1998: D'Andrea A D; Serhan C N
Relieving the Itch.
Nature genetics 1998;18(2):97-9.
1997: Kupfer G M; Näf D; D'Andrea A D
Molecular biology of Fanconi anemia.
Hematology/oncology clinics of North America 1997;11(6):1045-60.
1997: Kupfer G M; Näf D; Suliman A; Pulsipher M; D'Andrea A D
The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex.
Nature genetics 1997;17(4):487-90.
1997: Okuda K; D'Andrea A; Etten R A; Griffin J D
A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.
The Journal of clinical investigation 1997;100(7):1708-15.
1997: D'Andrea A D; Grompe M
Molecular biology of Fanconi anemia: implications for diagnosis and therapy.
Blood 1997;90(5):1725-36.
1997: Kupfer G M; Yamashita T; Naf D; Suliman A; Asano S; D'Andrea A D
The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2.
Blood 1997;90(3):1047-54.
1997: Jaster R; Zhu Y; Pless M; Bhattacharya S; Mathey-Prevot B; D'Andrea A D
JAK2 is required for induction of the murine DUB-1 gene.
Molecular and cellular biology 1997;17(6):3364-72.
1997: Pless M; Norga K; Carroll M; Heim M H; D'Andrea A D; Mathey-Prevot B
Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding.
Blood 1997;89(9):3175-85.
1997: Barber D L; Mason J M; Fukazawa T; Reedquist K A; Druker B J; Band H; D'Andrea A D
Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins.
Blood 1997;89(9):3166-74.
1997: Luo H; Rose P; Barber D; Hanratty W P; Lee S; Roberts T M; D'Andrea A D; Dearolf C R
Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways.
Molecular and cellular biology 1997;17(3):1562-71.
1997: Zhu Y; Lambert K; Corless C; Copeland N G; Gilbert D J; Jenkins N A; D'Andrea A D
DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.
The Journal of biological chemistry 1997;272(1):51-7.
1997: Barber D L; Corless C N; Xia K; Roberts T M; D'Andrea A D
Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells.
Blood 1997;89(1):55-64.
1997: Zhu Y; Hahn T; D'Andrea A D
Isolation of cytokine-inducible genes from hematopoietic cells by differential display.
Methods in molecular biology (Clifton, N.J.) 1997;85():153-61.
1996: Ku H; Hirayama F; Kato T; Miyazaki H; Aritomi M; Ota Y; D'Andrea A D; Lyman S D; Ogawa M
Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2.
Blood 1996;88(11):4124-31.
1996: D'Andrea A D
Fanconi anaemia forges a novel pathway.
Nature genetics 1996;14(3):240-2.
1996: Xia K; Mukhopadhyay N K; Inhorn R C; Barber D L; Rose P E; Lee R S; Narsimhan R P; D'Andrea A D; Griffin J D; Roberts T M
The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11681-6.
1996: Zhu Y; Pless M; Inhorn R; Mathey-Prevot B; D'Andrea A D
The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.
Molecular and cellular biology 1996;16(9):4808-17.
1996: Kupfer G M; D'Andrea A D
The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
Blood 1996;88(3):1019-25.
1996: Shikama Y; Barber D L; D'Andrea A D; Sieff C A
A constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell lines.
Blood 1996;88(2):455-64.
1996: Yamashita T; Wu N; Kupfer G; Corless C; Joenje H; Grompe M; D'Andrea A D
Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.
Blood 1996;87(10):4424-32.
1996: Zhu Y; Carroll M; Papa F R; Hochstrasser M; D'Andrea A D
DUB-1, a deubiquitinating enzyme with growth-suppressing activity.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(8):3275-9.
1996: D'Andrea A D; Zhu Y
Cloning and functional analysis of erythropoietin-, interleukin-3- and thrombopoietin-inducible genes.
Stem cells (Dayton, Ohio) 1996;14 Suppl 1():82-7.
1995: Carroll M; Zhu Y; D'Andrea A D
Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2869-73.
1994: D'Andrea A D
Hematopoietic growth factors and the regulation of differentiative decisions.
Current opinion in cell biology 1994;6(6):804-8.
1994: Boussiotis V A; Barber D L; Nakarai T; Freeman G J; Gribben J G; Bernstein G M; D'Andrea A D; Ritz J; Nadler L M
Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor.
Science (New York, N.Y.) 1994;266(5187):1039-42.
1994: Barber D L; D'Andrea A D
Erythropoietin and interleukin-2 activate distinct JAK kinase family members.
Molecular and cellular biology 1994;14(10):6506-14.
1994: Fisher M J; Prchal J F; Prchal J T; D'Andrea A D
Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera.
Blood 1994;84(6):1982-91.
1994: Carroll M; Mathey-Prevot B; D'Andrea A
Differentiation domains of the erythropoietin receptor.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1994;206(3):289-94.
1994: Yamashita T; Barber D L; Zhu Y; Wu N; D'Andrea A D
The Fanconi anemia polypeptide FACC is localized to the cytoplasm.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(14):6712-6.
1994: DeMartino J; Carroll M; Mathey-Prevot B; D'Andrea A D
Erythropoietin receptor contains both growth-promoting activity and differentiation-promoting activity.
Annals of the New York Academy of Sciences 1994;718():213-21; discussion 221-2.
1994: Barber D L; DeMartino J C; Showers M O; D'Andrea A D
A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation.
Molecular and cellular biology 1994;14(4):2257-65.
1994: Zhu Y; D'Andrea A D
The molecular physiology of erythropoietin and the erythropoietin receptor.
Current opinion in hematology 1994;1(2):113-8.
1994: D'Andrea A D
Cytokine receptors in congenital hematopoietic disease.
The New England journal of medicine 1994;330(12):839-46.
1993: Liboi E; Carroll M; D'Andrea A D; Mathey-Prevot B
Erythropoietin receptor signals both proliferation and erythroid-specific differentiation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(23):11351-5.
1993: D'Andrea A D; Rup B J; Fisher M J; Jones S
Anti-erythropoietin receptor (EPO-R) monoclonal antibodies inhibit erythropoietin binding and neutralize bioactivity.
Blood 1993;82(1):46-52.
1993: Galson D L; Hensold J O; Bishop T R; Schalling M; D'Andrea A D; Jones C; Auron P E; Housman D E
Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis.
Molecular and cellular biology 1993;13(5):2929-41.
1993: Showers M O; DeMartino J C; Saito Y; D'Andrea A D
Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line.
Molecular and cellular biology 1993;13(2):739-48.
1992: Showers M O; Moreau J F; Linnekin D; Druker B; D'Andrea A D
Activation of the erythropoietin receptor by the Friend spleen focus-forming virus gp55 glycoprotein induces constitutive protein tyrosine phosphorylation.
Blood 1992;80(12):3070-8.
1992: Barber D L; D'Andrea A D
The erythropoietin receptor and the molecular basis of signal transduction.
Seminars in hematology 1992;29(4):293-304.
1992: D'Andrea A D; Moreau J F; Showers M O
Molecular mimicry of erythropoietin by the spleen focus-forming virus gp55 glycoprotein: the first stage of Friend virus-induced erythroleukemia.
Biochimica et biophysica acta 1992;1114(1):31-41.
1992: Zon L I; Moreau J F; Koo J W; Mathey-Prevot B; D'Andrea A D
The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein.
Molecular and cellular biology 1992;12(7):2949-57.
1992: Emanuel P D; Eaves C J; Broudy V C; Papayannopoulou T; Moore M R; D'Andrea A D; Prchal J F; Eaves A C; Prchal J T
Familial and congenital polycythemia in three unrelated families.
Blood 1992;79(11):3019-30.
1992: D'Andrea A D
The interaction of the erythropoietin receptor and gp55.
Cancer surveys 1992;15():19-36.
1992: Showers M O; D'Andrea A D
Subunit structure and transmembrane signaling of the erythropoietin receptor.
International review of cytology 1992;137B():99-120.
1991: D'Andrea A D; Yoshimura A; Youssoufian H; Zon L I; Koo J W; Lodish H F
The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains.
Molecular and cellular biology 1991;11(4):1980-7.
1991: D'Andrea A D; Jones S S
Activation of the erythropoietin receptor in stable lymphoid and myeloid transfectants.
Seminars in hematology 1991;28(2):152-7.
1991: D'Andrea A D; Koo J W
Structure and function of the erythropoietin receptor in stable erythropoietin-dependent transfectants.
Contributions to nephrology 1991;88():48-56; discussion 57-8.
1990: Budarf M; Huebner K; Emanuel B; Croce C M; Copeland N G; Jenkins N A; D'Andrea A D
Assignment of the erythropoietin receptor (EPOR) gene to mouse chromosome 9 and human chromosome 19.
Genomics 1990;8(3):575-8.
1990: D'Andrea A D; Zon L I
Erythropoietin receptor. Subunit structure and activation.
The Journal of clinical investigation 1990;86(3):681-7.
1990: D'Andrea A D; Fasman G D; Lodish H F
A new hematopoietic growth factor receptor superfamily: structural features and implications for signal transduction.
Current opinion in cell biology 1990;2(4):648-51.
1990: Jones S S; D'Andrea A D; Haines L L; Wong G G
Human erythropoietin receptor: cloning, expression, and biologic characterization.
Blood 1990;76(1):31-5.
1990: Youssoufian H; Zon L I; Orkin S H; D'Andrea A D; Lodish H F
Structure and transcription of the mouse erythropoietin receptor gene.
Molecular and cellular biology 1990;10(7):3675-82.
1990: Yoshimura A; D'Andrea A D; Lodish H F
Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4139-43.
1990: Li J P; D'Andrea A D; Lodish H F; Baltimore D
Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
Nature 1990;343(6260):762-4.
1990: D'Andrea A D; Szklut P J; Lodish H F; Alderman E M
Inhibition of receptor binding and neutralization of bioactivity by anti-erythropoietin monoclonal antibodies.
Blood 1990;75(4):874-80.
1990: D'Andrea A D; Fasman G D; Zon L I; Li J P; Lodish H F
Structure of the erythropoietin receptor in stable fibroblast transfectants.
Progress in clinical and biological research 1990;352():153-9.
1989: D'Andrea A D; Fasman G D; Lodish H F
Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family.
Cell 1989;58(6):1023-4.
1989: Tsai S F; Martin D I; Zon L I; D'Andrea A D; Wong G G; Orkin S H
Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells.
Nature 1989;339(6224):446-51.
1989: D'Andrea A D; Lodish H F; Wong G G
Expression cloning of the murine erythropoietin receptor.
Cell 1989;57(2):277-85.
1989: Bellah R; D'Andrea A; Darillis E; Fellows K E
The association of congenital neuroblastoma and congenital heart disease. Is there a common embryologic basis?
Pediatric radiology 1989;19(2):119-21.
1987: D'Andrea A D; Packer R J; Rorke L B; Bilaniuk L T; Sutton L N; Bruce D A; Schut L
Pineocytomas of childhood. A reappraisal of natural history and response to therapy.
Cancer 1987;59(7):1353-7.
1986: D'Andrea A D; Plotkin S A; Douglas S D; Polin R A
Immune-specific gamma interferon production correlates with lymphocyte blastogenesis.
Journal of clinical microbiology 1986;23(5):911-5.
1986: D'Andrea A D; Bayever E; Haines K M; Wilmott R W; Polin R A; August C S; Douglas S D
Serial evaluation of lymphocyte function in bone marrow-grafted patients.
Diagnostic immunology 1986;4(6):281-7.
1983: D'Andrea A D; Tantravahi U; Lalande M; Perle M A; Latt S A
High resolution analysis of the timing of replication of specific DNA sequences during S phase of mammalian cells.
Nucleic acids research 1983;11(14):4753-74.
1980: Haseltine W A; Lo K M; D'Andrea A D
Preferred sites of strand scission in DNA modified by andi-diol epoxide of benzo[a]pyrene.
Science (New York, N.Y.) 1980;209(4459):929-31.
1980: Haseltine W A; Lindan C P; D'Andrea A D; Johnsrud L
The use of DNA fragments of defined sequence for the study of DNA damage and repair.
Methods in enzymology 1980;65(1):235-48.
1978: D'Andrea A D; Haseltine W A
Modification of DNA by aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(9):4120-4.
1978: D'Andrea A D; Haseltine W A
Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(8):3608-12.

Sign-in to see more